Challenges and Opportunities for Drug Discovery in Developing Countries: The Example of Cutaneous Leishmaniasis.

ACS Medicinal Chemistry Letters
Abdrrahman S SururAsrat Hailu

Abstract

The current drug discovery paradigm has failed to address the treatment need for diseases of high priority to developing countries. Cutaneous leishmaniasis is a good example of such diseases with virtually no new effective drug developed in the past 70 years. The past two decades had witnessed relatively increased attention toward neglected diseases by stimulating pharmaceutical industries through introductions of Priority Review Vouchers (PRVs) and Product Development Partnerships (PDPs). However, the lion's share of resources allocated for research and development by PRVs and PDPs is directed toward research organizations and pharmaceutical industries in developed countries. This new approach has also not led to the development of drugs for most neglected diseases including cutaneous leishmaniasis. Improving the medical discovery capacity of countries where these diseases are prevalent and enabling exploration of the hitherto untapped natural resources are an effective and sustainable solution.

References

Sep 29, 2000·BMJ : British Medical Journal·C Sitthi-Amorn, R Somrongthong
Mar 9, 2006·Health Affairs·David B RidleyJeffrey L Moe
Sep 1, 2006·Tanzania Health Research Bulletin·V A Nyigo, H M Malebo
Jul 9, 2010·PLoS Medicine·Solomon NwakaRobert G Ridley
Nov 18, 2011·Molecular Biology International·Arun Kumar HaldarSyamal Roy
Aug 9, 2012·BMJ : British Medical Journal·Donald W Light, Joel R Lexchin
Dec 25, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·M Fawzi Mahomoodally
Oct 28, 2014·Expert Opinion on Pharmacotherapy·Shyam Sundar, Jaya Chakravarty
Jan 21, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Begoña Monge-Maillo, Rogelio López-Vélez
Jul 6, 2015·Dermatologic Clinics·Ines KevricJames H Keeling
Feb 9, 2016·Journal of Natural Products·David J Newman, Gordon M Cragg
Mar 2, 2016·Journal of Health Economics·Joseph A DiMasiRonald W Hansen
Mar 5, 2016·PLoS Neglected Tropical Diseases·Johan van GriensvenErmias Diro
Mar 24, 2018·International Journal for Equity in Health·Chalachew AlemayehuJane Nikles
Jun 29, 2018·Infectious Diseases of Poverty·Hong-Bo WengMing-Wei Wang
Jun 14, 2019·EClinicalMedicine·Saskia van HentenJohan van Griensven
Dec 21, 2019·Health Research Policy and Systems·Rose N OronjeEliya M Zulu
Jan 19, 2020·Tropical Medicine and Infectious Disease·Emma Michelle Taylor, James Smith
May 23, 2020·BMC Medicine·Chikwe Ihekweazu, Emmanuel Agogo

❮ Previous
Next ❯

Citations

Dec 9, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jeysson Sánchez-SuárezEricsson Coy-Barrera
Nov 19, 2020·Drug Design, Development and Therapy·Abdrrahman Shemsu SururKaleab Asres
Jun 15, 2021·Frontiers in Molecular Biosciences·Lakshika SharmaM M Sharma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.